naltrexone and hmr 1098

naltrexone has been researched along with hmr 1098 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, Z; Liu, L; Van Winkle, DM	1

Other Studies

1 other study(ies) available for naltrexone and hmr 1098

Article	Year
Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels. American journal of physiology. Heart and circulatory physiology, 2003, Volume: 285, Issue:3 Topics: Adenosine Triphosphate; Animals; Benzamides; Cardiotonic Agents; Dose-Response Relationship, Drug; Dynorphins; Endorphins; Enkephalin, Methionine; Guanidines; Ischemic Preconditioning, Myocardial; Male; Mitochondria; Morphinans; Myocardial Ischemia; Myocytes, Cardiac; Naltrexone; Narcotic Antagonists; Potassium Channels; Rabbits; Receptors, Opioid, delta; Receptors, Opioid, kappa; Sarcolemma	2003

Article

Year

Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels.

American journal of physiology. Heart and circulatory physiology, 2003, Volume: 285, Issue:3

Topics: Adenosine Triphosphate; Animals; Benzamides; Cardiotonic Agents; Dose-Response Relationship, Drug; Dynorphins; Endorphins; Enkephalin, Methionine; Guanidines; Ischemic Preconditioning, Myocardial; Male; Mitochondria; Morphinans; Myocardial Ischemia; Myocytes, Cardiac; Naltrexone; Narcotic Antagonists; Potassium Channels; Rabbits; Receptors, Opioid, delta; Receptors, Opioid, kappa; Sarcolemma

2003